NM_002069.6:c.118+11834C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002069.6(GNAI1):c.118+11834C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 151,874 control chromosomes in the GnomAD database, including 6,504 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.26 ( 6504 hom., cov: 31)
Consequence
GNAI1
NM_002069.6 intron
NM_002069.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -4.14
Publications
6 publications found
Genes affected
GNAI1 (HGNC:4384): (G protein subunit alpha i1) Guanine nucleotide binding proteins are heterotrimeric signal-transducing molecules consisting of alpha, beta, and gamma subunits. The alpha subunit binds guanine nucleotide, can hydrolyze GTP, and can interact with other proteins. The protein encoded by this gene represents the alpha subunit of an inhibitory complex. The encoded protein is part of a complex that responds to beta-adrenergic signals by inhibiting adenylate cyclase. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
GNAI1 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalitiesInheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Broad Center for Mendelian Genomics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.332 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.265 AC: 40172AN: 151754Hom.: 6498 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
40172
AN:
151754
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.265 AC: 40185AN: 151874Hom.: 6504 Cov.: 31 AF XY: 0.268 AC XY: 19923AN XY: 74230 show subpopulations
GnomAD4 genome
AF:
AC:
40185
AN:
151874
Hom.:
Cov.:
31
AF XY:
AC XY:
19923
AN XY:
74230
show subpopulations
African (AFR)
AF:
AC:
3064
AN:
41454
American (AMR)
AF:
AC:
5188
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
1242
AN:
3470
East Asian (EAS)
AF:
AC:
1336
AN:
5128
South Asian (SAS)
AF:
AC:
1330
AN:
4808
European-Finnish (FIN)
AF:
AC:
4437
AN:
10506
Middle Eastern (MID)
AF:
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22532
AN:
67944
Other (OTH)
AF:
AC:
632
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1391
2782
4172
5563
6954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
881
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.